PHENYTOIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for phenytoin and what is the scope of patent protection?
Phenytoin
is the generic ingredient in ten branded drugs marketed by Viatris, Actavis Mid Atlantic, Pai Holdings Pharm, Taro, Vistapharm, Pharmacia, Epic Pharma Llc, Rising, Chartwell Molecular, Amneal Pharms Ny, Ani Pharms, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Unichem, Wockhardt, Wockhardt Usa, Watson Labs, Aurobindo Pharma, Pharmeral, Parke Davis, Acella, Am Regent, Fresenius Kabi Usa, Hospira, Marsam Pharms Llc, Smith And Nephew, Solopak, Warner Chilcott, and West-ward Pharms Int, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-one drug master file entries for phenytoin. Twelve suppliers are listed for this compound.
Summary for PHENYTOIN
US Patents: | 0 |
Tradenames: | 10 |
Applicants: | 31 |
NDAs: | 42 |
Drug Master File Entries: | 21 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 155 |
Clinical Trials: | 127 |
Patent Applications: | 6,781 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for PHENYTOIN |
Drug Sales Revenues: | Drug sales revenues for PHENYTOIN |
What excipients (inactive ingredients) are in PHENYTOIN? | PHENYTOIN excipients list |
DailyMed Link: | PHENYTOIN at DailyMed |
Recent Clinical Trials for PHENYTOIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sohag University | Phase 2/Phase 3 |
Dr Cipto Mangunkusumo General Hospital | Phase 4 |
Wayne State University | Phase 4 |